Author:
Marathe Gopal Kedihithlu,Jacob Shancy Petsel,Sumanth Mosale Seetharam,Lakshmikanth Chikkamenahalli Lakshminarayana,Abhilash Kandahalli Venkataranganayaka,Chaithra Vyala Hanumanthareddy
Reference26 articles.
1. Bhosle VK, Rivera JC, Zhou T, Omri S, Sanchez M, Hamel D, et al. Nuclear localization of platelet-activating factor receptor controls retinal neovascularisation. Cell Discov. 2016;2:16017
2. Blank ML, Snyder F, Byers LW, Brooks B, Muirhead EE. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun. 1979;90:1194–200.
3. Blank ML, Lee T-C, Fitzgerald V, Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem. 1981;256:175–8.
4. Chen J, Yang L, Foulks JM, Weyrich AS, Marathe GK, McIntyre TM. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis. J Lipid Res. 2007;48:2365–76.
5. Chen R, Brady E, McIntyre TM. Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells. J Immunol. 2011;186:3215–25